Researches on the correlation between estrogen and progesterone receptors expression and disease-free survival of endometrial cancer

S Ren, J Wu, W Yin, Q Liao, S Gong… - Cancer Management …, 2020 - Taylor & Francis
Objective In this study, 345 patients with endometrial carcinoma (EC) were selected to
investigate the correlation between ER/PR status and the EC disease-free survival (DFS) …

Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer

JT Chambers, N MacLusky, A Eisenfield, EI Kohorn… - Gynecologic …, 1988 - Elsevier
The survival of 213 postmenopausal patients with primary endometrial cancer was analyzed
as a function of clinicopathologic features and cytosol steroid receptor levels. Estrogen …

Expression of estrogen receptor-alpha and-beta and progesterone receptor-A and-B in a large cohort of patients with endometrioid endometrial cancer

V Jongen, J Briët, R de Jong, K ten Hoor, M Boezen… - Gynecologic …, 2009 - Elsevier
OBJECTIVE: The estrogen receptor (ER)-alpha and-beta and progesterone receptor (PR)-A
and-B were determined in endometrioid endometrial cancer, and their prognostic values …

Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis

Y Zhang, D Zhao, C Gong, F Zhang, J He… - World journal of surgical …, 2015 - Springer
Background The aim of this study was to summarize the global predicting role of hormone
receptors for survival in endometrial cancer. Methods Eligible studies were identified and …

The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer …

WJ Van Weelden, C Reijnen… - Human Pathology, 2021 - Elsevier
There is no consensus on the cutoff for positivity of estrogen receptor (ER) and progesterone
receptor (PR) in endometrial cancer (EC). Therefore, we determined the cutoff value for ER …

Estrogen receptor-and progesterone receptor-positive thresholds in predicting the recurrence of early low-risk Endometrial Cancer

N Li, P Jiang, Y Huang, Y Tu, W Kong… - Clinical Medicine …, 2022 - journals.sagepub.com
Background: Estrogen receptors (ER) and progesterone receptors (PR) have important
prognostic value in endometrial cancer, but there is no recognized positive …

Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial …

M Köbel, EG Atenafu, PF Rambau, SE Ferguson… - Gynecologic …, 2016 - Elsevier
Objective To assess the association of hormone receptor expression with outcome in high-
grade endometrial carcinomas. Methods This study included three sites participating in the …

[HTML][HTML] Estrogen receptor, progesterone receptor, and HER2 receptor markers in endometrial cancer

C Wang, DA Tran, MZ Fu, W Chen, SW Fu, X Li - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
Background: Endometrial cancer (EC) is a major gynecologic adenocarcinoma that arises
from the endometrium. While the incidence of EC is on the rise worldwide, survivorship and …

Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer

D Tomica, S Ramić, D Danolić, L Šušnjar… - Journal of obstetrics …, 2018 - Taylor & Francis
Loss of oestrogen receptor (ER) and progesterone receptor (PR) expression in endometrial
cancer cells indicates poor prognosis. The aim of this study was to determine the correlation …

ER and PR expression and survival after endometrial cancer

D Smith, CJR Stewart, EM Clarke, F Lose, C Davies… - Gynecologic …, 2018 - Elsevier
Objective To measure association between endometrial carcinoma ER and PR status and
endometrial cancer (EC) survival, accounting for inter-observer variation. Methods The …